Search results for metastatic carcinoma

1500 hits were found for metastatic carcinoma

# Family MCID Name MIFTS Score
1
P RNL003 Renal Clear Cell Carcinoma 58 4.310
2
CLR030 Clear Cell Renal Cell Carcinoma 55 3.959
3
SQM006 Squamous Cell Carcinoma 74 1.081
4
RNL114 Renal Cell Carcinoma, Nonpapillary 68 1.022
5
P HPT023 Hepatocellular Carcinoma 94 0.886
6
P ADN016 Adenocarcinoma 71 0.868
7
P BRS047 Breast Cancer 100 0.753
8
P THY032 Thyroiditis 56 0.671
9
MLN008 Melanoma 72 0.641
10
PRS047 Prostatitis 59 0.598
11
P CLR023 Colorectal Cancer 98 0.584
12
BRS051 Breast Disease 67 0.520
13
c BLD140 Blood Group, I System 37 0.488
14
P PRS040 Prostate Cancer 88 0.478
15
c OVR114 Ovarian Cancer 1 54 0.463
16
P LNG032 Lung Cancer 99 0.454
17
P ESP024 Esophagitis 64 0.453
18
SKN016 Skin Disease 68 0.452
19
SKN027 Skin Conditions 48 0.448
20
P KDN017 Kidney Cancer 66 0.442
21
P NSP012 Nasopharyngeal Carcinoma 71 0.439
22
URN009 Urinary System Disease 58 0.435
23
TRN018 Transitional Cell Carcinoma 58 0.431
24
NRN004 Neuroendocrine Tumor 58 0.423
25
P INT068 Intestinal Disease 65 0.420
26
P KDN018 Kidney Disease 69 0.418
27
ORL015 Oral Squamous Cell Carcinoma 59 0.413
28
RCT017 Rectal Disease 38 0.411
29
c BSL007 Basal Cell Carcinoma 66 0.410
30
P PNC044 Pancreatitis 64 0.407
31
CLN019 Colonic Disease 55 0.405
32
SQM013 Squamous Cell Carcinoma, Head and Neck 79 0.401
33
EWN002 Ewing's Family of Tumors 49 0.387
34
P CRV039 Cervicitis 49 0.382
35
c BSL024 Basal Cell Carcinoma 1 42 0.378
36
P HPT021 Hepatitis 75 0.375
37
P THY109 Thyroid Cancer, Nonmedullary, 1 64 0.366
38
NSP002 Nasopharyngitis 46 0.358
39
SKN019 Skin Melanoma 63 0.357
40
SRC014 Sarcoma 68 0.352
41
P PNC035 Pancreatic Cancer 89 0.349
42
END072 Endotheliitis 46 0.344
43
P LVR013 Liver Disease 76 0.340
44
P SML001 Small Cell Carcinoma 58 0.336
45
P LRY019 Laryngitis 57 0.328
46
PRS042 Prostate Disease 56 0.316
47
MRK001 Merkel Cell Carcinoma 59 0.315
48
ADN018 Adenoma 63 0.306
49
GST053 Gastric Cancer 84 0.304
50
P BRN120 Bronchus Cancer 39 0.286
51
ADN002 Adenoiditis 40 0.281
52
PPL002 Papillary Carcinoma 51 0.279
53
THY111 Thyroid Carcinoma, Familial Medullary 63 0.274
54
PNC034 Pancreas Disease 59 0.274
55
ADR054 Adrenocortical Carcinoma, Hereditary 63 0.271
56
MCP006 Mucoepidermoid Carcinoma 51 0.265
57
DCT002 Ductal Carcinoma in Situ 56 0.264
58
ADR004 Adrenal Cortical Adenocarcinoma 47 0.257
59
P OVR042 Ovarian Cancer 82 0.253
60
P LYM118 Lymphoma 71 0.253
61
GST050 Gastrointestinal System Disease 66 0.252
62
ESP021 Esophageal Cancer 79 0.250
63
SFT003 Soft Tissue Sarcoma 58 0.244
64
c SML038 Small Cell Cancer of the Lung 67 0.243
65
P BLD134 Bladder Cancer 78 0.243
66
c THY102 Thyroid Cancer, Nonmedullary, 2 57 0.241
67
PRT010 Parathyroid Carcinoma 64 0.240
68
HYP266 Hypoxia 61 0.232
69
ADN009 Adenosquamous Carcinoma 54 0.232
70
PNC033 Pancreas Adenocarcinoma 63 0.221
71
c MLG074 Malignant Mesenchymoma 51 0.220
72
SPP010 Suppressor of Tumorigenicity 3 55 0.217
73
ESP023 Esophageal Disease 58 0.216
74
PHR003 Pharyngitis 59 0.214
75
CHL065 Cholangiocarcinoma 70 0.212
76
RNL065 Renal Cell Carcinoma, Papillary, 1 56 0.212
77
SPP011 Suppression of Tumorigenicity 12 41 0.210
78
FXF002 Fox-Fordyce Disease 40 0.209
79
BLD034 Bile Duct Carcinoma 60 0.207
80
VRL011 Viral Infectious Disease 64 0.205
81
STM006 Stomach Disease 52 0.204
82
DFF036 Differentiated Thyroid Carcinoma 49 0.204
83
THY028 Thyroid Cancer 72 0.201
84
SLV012 Salivary Gland Adenoid Cystic Carcinoma 54 0.198
85
CLN015 Colon Adenocarcinoma 53 0.196
86
PRT036 Peritonitis 67 0.194
87
CRV038 Cervical Squamous Cell Carcinoma 61 0.192
88
P LKM002 Leukemia 75 0.191
89
LYM006 Lymphoepithelioma-Like Carcinoma 46 0.191
90
NSP003 Nasopharyngeal Disease 34 0.190
91
SQM022 Squamous Cell Carcinoma of the Larynx 45 0.187
92
LNG039 Lung Squamous Cell Carcinoma 60 0.187
93
P OVR106 Ovarian Clear Cell Carcinoma 45 0.185
94
c RTN162 Retinitis Pigmentosa 2 50 0.184
95
P TRT010 Teratoma 53 0.180
96
END057 Endometrial Cancer 76 0.180
97
PPL022 Papilloma 58 0.179
98
c HPT016 Hepatitis B 68 0.179
99
ACN001 Acinar Cell Carcinoma 52 0.179
100
P LRG014 Large Cell Neuroendocrine Carcinoma 37 0.178
101
P GRM010 Germ Cells Tumors 37 0.178
102
ACQ007 Acquired Immunodeficiency Syndrome 65 0.178
103
BLD044 Bladder Disease 55 0.177
104
SPN032 Spindle Cell Carcinoma 43 0.176
105
P CRV035 Cervical Cancer 72 0.175
106
EMB004 Embryonal Carcinoma 59 0.175
107
BLD131 Bladder Urothelial Carcinoma 55 0.174
108
GST040 Gastric Adenocarcinoma 60 0.172
109
CHR177 Chromophobe Renal Cell Carcinoma 59 0.172
110
P HYP086 Hypothyroidism 62 0.172
111
RCT020 Rectum Adenocarcinoma 25 0.171
112
SQM023 Squamous Cell Carcinoma of the Oropharynx 44 0.171
113
GND003 Gonadal Disease 32 0.167
114
P UTR058 Uterine Anomalies 55 0.165
115
BRR014 Barrett Esophagus 64 0.162
116
P LMY004 Leiomyosarcoma 59 0.161
117
ADR005 Adrenal Carcinoma 59 0.161
118
AGN016 Aging 65 0.161
119
RCT018 Rectal Neoplasm 53 0.160
120
P NRB001 Neuroblastoma 73 0.160
121
ORP003 Oropharynx Cancer 51 0.160
122
CRV040 Cervix Carcinoma 52 0.157
123
GST019 Gastrointestinal Stromal Tumor 74 0.157
124
P ORL007 Oral Cavity Cancer 59 0.156
125
TNG009 Tongue Squamous Cell Carcinoma 57 0.156
126
c INS002 in Situ Carcinoma 56 0.155
127
THY030 Thyroid Gland Disease 51 0.154
128
OCL033 Oculocerebral Syndrome with Hypopigmentation 31 0.154
129
CHR008 Choroiditis 47 0.154
130
LYM019 Lymphosarcoma 58 0.153
131
P LRY044 Larynx Cancer 57 0.152
132
CHR074 Choriocarcinoma 49 0.152
133
SQM021 Squamous Cell Carcinoma of the Hypopharynx 42 0.152
134
ORL011 Oral Cancer 60 0.152
135
SPS003 Spastic Diplegia 55 0.152
136
P OVR049 Ovarian Disease 58 0.151
137
LRY017 Laryngeal Disease 38 0.150
138
CLL002 Collecting Duct Carcinoma 43 0.150
139
CLR109 Colorectal Adenocarcinoma 54 0.150
140
OVR094 Ovarian Epithelial Cancer 46 0.148
141
BSL006 Basaloid Squamous Cell Carcinoma 43 0.148
142
EPT010 Epithelial-Myoepithelial Carcinoma 48 0.147
143
P LPS002 Liposarcoma 61 0.147
144
P HYP726 Hypercalcemia, Infantile, 1 57 0.147
145
P RHB003 Rhabdomyosarcoma 61 0.147
146
PLM014 Pleomorphic Adenoma 55 0.145
147
c LRG001 Large Cell Carcinoma 50 0.145
148
P PRG013 Paraganglioma 57 0.144
149
ESP027 Esophagus Squamous Cell Carcinoma 45 0.144
150
MCN001 Mucinous Adenocarcinoma 54 0.144
151
ANG020 Angiosarcoma 57 0.143
152
c HPT001 Hepatitis C 73 0.143
153
THR024 Thrombosis 61 0.142
154
BLR007 Biliary Tract Neoplasm 53 0.142
155
GLL018 Gallbladder Cancer 67 0.141
156
P CNN004 Connective Tissue Cancer 35 0.140
157
ALP072 Alpha-Fetoprotein Deficiency 32 0.140
158
c SML034 Small Cell Neuroendocrine Carcinoma 39 0.139
159
c PRM126 Primary Peritoneal Carcinoma 59 0.139
160
P MLN069 Melanoma, Uveal 63 0.139
161
CRB006 Cribriform Carcinoma 41 0.137
162
SRC002 Sarcomatoid Renal Cell Carcinoma 42 0.137
163
BNC003 Bone Cancer 59 0.137
164
c INF023 Inflammatory Breast Carcinoma 54 0.135
165
P THY023 Thymoma 65 0.135
166
UTR033 Uterine Corpus Cancer 51 0.135
167
CRC006 Carcinoid Syndrome 59 0.133
168
P PHC003 Pheochromocytoma 72 0.133
169
P RTN024 Retinoblastoma 76 0.133
170
INS001 Insulinoma 66 0.133
171
BRS099 Breast Ductal Carcinoma 55 0.133
172
LYM024 Lymphatic System Disease 45 0.132
173
CHR603 Chronic Enteropathy Associated with Slco2a1 Gene 21 0.132
174
SMN007 Seminoma 49 0.132
175
INS024 Insulin-Like Growth Factor I 83 0.132
176
HYP082 Hypopharynx Cancer 47 0.131
177
P SLV002 Salivary Gland Cancer 62 0.130
178
ONC007 Oncocytoma 48 0.129
179
LVR012 Liver Cirrhosis 73 0.129
180
P KRT005 Keratoacanthoma 49 0.129
181
BRN028 Brain Cancer 72 0.128
182
PNC041 Pancreatic Ductal Adenocarcinoma 67 0.127
183
P GST049 Gastrointestinal System Cancer 60 0.126
184
FLL027 Fallopian Tube Carcinoma 62 0.126
185
P MLT074 Multiple Endocrine Neoplasia 55 0.125
186
THY049 Thyroid Cancer, Anaplastic 53 0.125
187
CYS014 Cystadenocarcinoma 51 0.125
188
MTH009 Mouth Disease 64 0.125
189
c TRC078 Trichohepatoenteric Syndrome 2 34 0.124
190
MDS022 Mediastinitis 44 0.124
191
P PRN020 Paranasal Sinus Cancer 44 0.123
192
KRT009 Keratosis 53 0.122
193
MCS002 Mucositis 61 0.122
194
PNC013 Pancreatic Ductal Carcinoma 47 0.121
195
P CYS017 Cystic Teratoma 40 0.121
196
P FBR017 Fibrosarcoma 61 0.121
197
TST014 Testicular Cancer 54 0.121
198
INT079 Intrahepatic Cholangiocarcinoma 60 0.120
199
SKN022 Skin Squamous Cell Carcinoma 46 0.120
200
ANG018 Angiomyolipoma 50 0.119
201
P CRV031 Cervical Adenocarcinoma 55 0.119
202
P NRP001 Neuropathy 63 0.119
203
ISL001 Islet Cell Tumor 54 0.119
204
BLR006 Biliary Tract Disease 55 0.118
205
ANL017 Anal Squamous Cell Carcinoma 49 0.118
206
c HPT073 Hepatitis C Virus 73 0.118
207
HST009 Histiocytoma 51 0.117
208
ESP025 Esophagus Adenocarcinoma 42 0.117
209
SRC027 Sarcoma, Synovial 58 0.117
210
c THY107 Thymoma, Familial 34 0.116
211
P TRC086 Trichohepatoenteric Syndrome 1 54 0.116
212
LRY011 Larynx Verrucous Carcinoma 31 0.115
213
NRV006 Nervous System Cancer 61 0.115
214
EWN003 Ewing Sarcoma 72 0.115
215
DDN006 Duodenitis 46 0.115
216
P PNL012 Penile Cancer 58 0.114
217
P BRS044 Breast Adenocarcinoma 58 0.114
218
END041 Endometrial Adenocarcinoma 59 0.113
219
LRG016 Large Intestine Adenocarcinoma 37 0.113
220
P EST001 Estrogen-Receptor Positive Breast Cancer 52 0.113
221
LNT001 Linitis Plastica 36 0.112
222
OST159 Osteogenic Sarcoma 70 0.112
223
PNC015 Pancreatic Acinar Cell Adenocarcinoma 35 0.112
224
OCL009 Ocular Cancer 61 0.111
225
TNG003 Tongue Cancer 63 0.111
226
P GLM045 Glioma 61 0.111
227
ALP042 Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 63 0.111
228
c EPS039 Episodic Pain Syndrome, Familial, 1 33 0.111
229
ALV005 Alveolar Soft Part Sarcoma 56 0.111
230
CRV069 Cervix Disease 39 0.111
231
OVR105 Ovarian Serous Carcinoma 43 0.111
232
c MNN043 Meningioma, Familial 69 0.110
233
P LNG064 Lung Cancer Susceptibility 3 64 0.109
234
c ADL096 Adult Hepatocellular Carcinoma 47 0.109
235
CHR072 Chordoma 61 0.109
236
CRC034 Carcinoma Showing Thymus-Like Differentiation 24 0.109
237
P NTR004 Neutropenia 60 0.108
238
P HMN036 Hemangiopericytoma, Malignant 52 0.108
239
P RNL017 Renal Oncocytoma 49 0.108
240
FBR003 Fibrous Histiocytoma 46 0.108
241
GLB002 Glioblastoma 74 0.108
242
c LKM071 Leukemia, Chronic Lymphocytic 75 0.108
243
EPT012 Epithelioid Sarcoma 47 0.108
244
PLM016 Pleomorphic Carcinoma 38 0.107
245
PLM009 Pleomorphic Adenoma Carcinoma 28 0.107
246
P MDL005 Medulloblastoma 76 0.107
247
P ACT008 Actinic Keratosis 56 0.107
248
CMP080 Complement Hyperactivation, Angiopathic Thrombosis, and Protein-Losing Enteropathy 40 0.106
249
PNC008 Pancreatic Endocrine Carcinoma 40 0.106
250
SCL017 Sclerosing Hemangioma 41 0.106
251
P BCL006 B-Cell Lymphomas 70 0.106
252
P TST021 Testicular Germ Cell Tumor 70 0.105
253
VCC001 Vaccinia 50 0.105
254
INV006 Inverted Papilloma 36 0.105
255
LYM143 Lymphoma, Non-Hodgkin, Familial 71 0.105
256
PRN039 Paraneoplastic Syndromes 35 0.105
257
NRN002 Neuronitis 43 0.105
258
THR100 Thrombocytopenic Purpura, Autoimmune 57 0.104
259
c THR001 Thrombocytopenia Due to Platelet Alloimmunization 53 0.104
260
GTR002 Goiter 53 0.104
261
LYM133 Lymphoma, Hodgkin, Classic 78 0.104
262
VNH007 Von Hippel-Lindau Syndrome 72 0.104
263
P DRR001 Diarrhea 60 0.104
264
URT031 Ureteral Disease 50 0.104
265
GST071 Gastrointestinal Carcinoma 40 0.104
266
c LKM004 Leukemia, B-Cell, Chronic 37 0.103
267
GST030 Gastrinoma 44 0.103
268
P CHN012 Chondrosarcoma 56 0.103
269
LNG099 Lung Disease 67 0.102
270
SLV003 Salivary Gland Disease 47 0.102
271
CLR003 Clear Cell Adenocarcinoma 57 0.102
272
c BRS049 Breast Carcinoma in Situ 55 0.102
273
MLG077 Malignant Peripheral Nerve Sheath Tumor 59 0.102
274
GST012 Gastroesophageal Junction Adenocarcinoma 36 0.101
275
MYL069 Myeloma, Multiple 86 0.100
276
CHL067 Cholecystitis 58 0.100
277
P AST007 Astrocytoma 66 0.100
278
CNN003 Conn's Syndrome 70 0.100
279
END031 Endometrial Stromal Sarcoma 53 0.100
280
MYM001 Myoma 56 0.100
281
SMT003 Somatostatinoma 54 0.100
282
OCL022 Ocular Melanoma 41 0.100
283
GLB015 Glioblastoma Multiforme 68 0.100
284
SNN002 Sinonasal Undifferentiated Carcinoma 31 0.100
285
P STR021 Struma Ovarii 40 0.100
286
P MYC084 Mycobacterium Tuberculosis 1 69 0.099
287
c MST023 Mesothelioma, Malignant 61 0.099
288
P PNM007 Pneumonia 70 0.099
289
SPN404 Spinal and Bulbar Muscular Atrophy, X-Linked 1 59 0.099
290
PTT008 Pituitary Carcinoma 51 0.099
291
PNC119 Pancreatic Neuroendocrine Tumor 49 0.099
292
OLF005 Olfactory Neuroblastoma 48 0.099
293
UTR024 Uterine Carcinosarcoma 57 0.098
294
MTS005 Metastatic Squamous Neck Cancer with Occult Primary 14 0.098
295
ERY003 Erythema Multiforme 60 0.097
296
P HYP069 Hyperparathyroidism 58 0.097
297
GRN017 Granulocytopenia 49 0.096
298
AML004 Ameloblastic Carcinoma 35 0.095
299
BNS001 Bone Osteosarcoma 38 0.095
300
PHC013 Phaeochromocytoma 44 0.095
301
P OLG002 Oligodendroglioma 59 0.095
302
HDR006 Hidradenocarcinoma 47 0.095
303
PRT035 Peritoneum Cancer 42 0.094
304
P AST055 Asthma-Related Traits 1 18 0.094
305
HMN009 Hemangioblastoma 56 0.093
306
MNT001 Mantle Cell Lymphoma 76 0.093
307
CLT003 Colitis 63 0.093
308
c PNL017 Penile Cancer, Adult 22 0.093
309
PPL018 Papillary Adenocarcinoma 47 0.092
310
P TST026 Testicular Germ Cell Cancer 44 0.092
311
P URT040 Urethral Cancer 24 0.092
312
P ANR048 Aniridia 1 68 0.092
313
ANR038 Anorexia Nervosa 1 21 0.092
314
BLD137 Blood Group--Ahonen 17 0.092
315
ANL011 Anal Canal Carcinoma 36 0.091
316
CRB009 Cerebritis 41 0.091
317
CYS009 Cystadenoma 44 0.090
318
c URT035 Urethral Benign Neoplasm 27 0.090
319
HPT022 Hepatoblastoma 55 0.090
320
c HPT003 Hepatitis a 63 0.089
321
CLC003 Cloacogenic Carcinoma 35 0.089
322
BRK010 Burkitt Lymphoma 71 0.089
323
CRC014 Carcinoid Tumors, Intestinal 46 0.088
324
DFF005 Diffuse Large B-Cell Lymphoma 64 0.088
325
LMY003 Leiomyomatosis 45 0.088
326
LMY002 Leiomyoma 58 0.088
327
c WLM011 Wilms Tumor 6 44 0.088
328
P GNT008 Giant Cell Tumor 49 0.088
329
P OBS001 Obstructive Jaundice 53 0.087
330
SGN002 Signet Ring Cell Adenocarcinoma 47 0.087
331
HRS011 Horseshoe Kidney 35 0.087
332
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 40 0.087
333
GLC036 Glucagonoma 52 0.087
334
P EXN002 Exanthem 62 0.087
335
SQM024 Squamous Cell Carcinoma of the Salivary Glands 14 0.087
336
DRM014 Dermatofibrosarcoma Protuberans 63 0.086
337
ANS011 Anus Cancer 46 0.086
338
MTR010 Mature Teratoma 46 0.086
339
P MNN013 Meningitis 71 0.086
340
P GLL020 Gallbladder Disease 64 0.086
341
P RNG031 Ring Chromosome Y Syndrome 29 0.085
342
LYM129 Lymphoma, Mucosa-Associated Lymphoid Type 67 0.085
343
VGN023 Vaginitis 59 0.085
344
FLL029 Fallopian Tube Disease 35 0.085
345
CHN070 Cohen-Gibson Syndrome 51 0.085
346
P ANP001 Anaplastic Large Cell Lymphoma 60 0.085
347
ZLL002 Zollinger-Ellison Syndrome 57 0.084
348
FBR086 Fibrolamellar Carcinoma 50 0.084
349
P HMN010 Hemangioma 61 0.084
350
ADN013 Adenoid Squamous Cell Carcinoma 30 0.084
351
P DRM010 Dermatomyositis 65 0.084
352
FML037 Female Breast Cancer 52 0.084
353
P INF032 Infertility 59 0.084
354
END075 Endocervical Adenocarcinoma 36 0.083
355
ECC004 Eccrine Porocarcinoma 38 0.083
356
BRN106 Burns 57 0.083
357
THY025 Thymus Cancer 52 0.083
358
P SML016 Small Intestine Cancer 52 0.083
359
UND005 Undifferentiated Pleomorphic Sarcoma 59 0.083
360
URT051 Ureter, Cancer of 43 0.083
361
HMT002 Hematologic Cancer 64 0.083
362
P END044 Endometriosis 71 0.083
363
P LYM026 Lymphoblastic Leukemia 66 0.082
364
c MLT160 Multiple Endocrine Neoplasia, Type Iia 65 0.082
365
UTR043 Uterine Sarcoma 48 0.082
366
PRT029 Parathyroid Adenoma 50 0.082
367
PRT018 Portal Vein Thrombosis 50 0.081
368
CHR176 Chromophil Renal Cell Carcinoma 19 0.081
369
c MLG081 Malignant Teratoma 46 0.081
370
MYC006 Mycosis Fungoides 73 0.081
371
ANX010 Anxiety 72 0.081
372
THR004 Thrombocytosis 55 0.081
373
P FLL037 Follicular Lymphoma 76 0.081
374
BSS001 Basosquamous Carcinoma 26 0.081
375
SML031 Small Cell Carcinoma of the Bladder 34 0.080
376
DYS073 Dysphagia 47 0.080
377
NRF007 Neurofibroma 65 0.080
378
c EST002 Estrogen-Receptor Negative Breast Cancer 44 0.080
379
BLD047 Bladder Squamous Cell Carcinoma 43 0.080
380
c MYT021 Myotonic Dystrophy 1 68 0.080
381
HYP056 Hypoglycemia 62 0.080
382
KRT003 Keratinizing Squamous Cell Carcinoma 37 0.080
383
CNG034 Congestive Heart Failure 74 0.079
384
NNS011 Nonseminomatous Germ Cell Tumor 35 0.079
385
P EPT020 Epithelioid Hemangioendothelioma 50 0.079
386
P FML011 Familial Adenomatous Polyposis 71 0.079
387
FLL031 Follicular Adenoma 41 0.079
388
MLG098 Malignant Mixed Mullerian Tumor 37 0.079
389
BLD036 Bile Duct Disease 52 0.078
390
VPM001 Vipoma 52 0.078
391
PNC053 Pancreatic Islet Cell Tumors 39 0.078
392
TNS005 Tonsillitis 61 0.078
393
c MLG079 Malignant Pleural Mesothelioma 54 0.078
394
GLL017 Gallbladder Adenocarcinoma 46 0.078
395
SYN046 Syndrome of Inappropriate Antidiuretic Hormone 44 0.078
396
PNC006 Pancreatic Somatostatinoma 39 0.078
397
PLS025 Plasmablastic Lymphoma 51 0.078
398
OVR112 Ovarian Germ Cell Cancer 42 0.078
399
BLD039 Bladder Adenocarcinoma 34 0.078
400
DRM006 Dermatitis 67 0.078
401
PPL007 Papillary Serous Adenocarcinoma 45 0.078
402
P ART022 Arthritis 77 0.078
403
MMM001 Mammary Paget's Disease 51 0.077
404
HMN016 Hemangioendothelioma 43 0.077
405
PLS011 Plasmacytoma 60 0.077
406
SRS001 Serous Cystadenocarcinoma 55 0.077
407
MLG065 Malignant Fibroxanthoma 41 0.077
408
P ENC018 Encephalopathy 58 0.077
409
P LYN001 Lynch Syndrome 71 0.076
410
DSM007 Desmoplastic Small Round Cell Tumor 53 0.076
411
c ADL017 Adult T-Cell Leukemia 63 0.076
412
NSD001 Nose Disease 51 0.076
413
P THR014 Thrombocytopenia 65 0.076
414
INT051 Intussusception 51 0.076
415
P HRP006 Herpes Simplex 70 0.076
416
P END039 Endodermal Sinus Tumor 44 0.076
417
c RHB024 Rhabdomyosarcoma 2 56 0.076
418
DRM013 Dermoid Cyst 43 0.076
419
APC004 Apocrine Adenocarcinoma 38 0.076
420
RTC009 Reticulum Cell Sarcoma 51 0.076
421
CRV033 Cervical Adenosquamous Carcinoma 43 0.075
422
PSD007 Pseudomyxoma Peritonei 54 0.075
423
P PRG002 Progesterone-Receptor Positive Breast Cancer 40 0.075
424
P EPN002 Ependymoma 53 0.075
425
ADR012 Adrenal Gland Disease 51 0.075
426
c PRG003 Progesterone-Receptor Negative Breast Cancer 37 0.075
427
P LPS004 Lupus Erythematosus 69 0.075
428
PRN021 Paranasal Sinus Disease 51 0.075
429
P TBR001 Tuberous Sclerosis 69 0.075
430
HDG004 Hodgkin's Granuloma 28 0.075
431
HDG006 Hodgkin's Paragranuloma 21 0.075
432
CRD001 Cardiac Tamponade 45 0.075
433
EXT027 Extrahepatic Bile Duct Adenocarcinoma 36 0.075
434
P ACT074 Acute Lymphocytic Leukemia 61 0.075
435
VLV032 Vulva Cancer 47 0.074
436
MYX005 Myxoid Liposarcoma 56 0.074
437
c MLN043 Melanoma, Cutaneous Malignant 8 26 0.074
438
MRG013 Mirage Syndrome 44 0.073
439
c TST046 Testicular Germ Cell Tumor 1 26 0.073
440
GYN001 Gynecomastia 47 0.073
441
P HYP076 Hyperthyroidism 56 0.073
442
PLS009 Plasma Cell Neoplasm 51 0.073
443
c CLR017 Clear Cell Sarcoma 50 0.073
444
BSL036 Basal Cell Nevus Syndrome 67 0.073
445
EPD001 Epidermodysplasia Verruciformis 52 0.073
446
GLS001 Gliosarcoma 61 0.073
447
LYM027 Lymphopenia 56 0.073
448
BNF002 Bone Fracture 56 0.073
449
P LCH002 Lichen Planus 58 0.073
450
STM007 Stomatitis 52 0.073
451
P SNS014 Sinusitis 62 0.072
452
LYM040 Lymphoblastic Lymphoma 58 0.072
453
MRG003 Marginal Zone B-Cell Lymphoma 56 0.072
454
LYM049 Lymphoma, Small Cleaved-Cell, Diffuse 36 0.072
455
TRN058 Transitional Cell Cancer of the Renal Pelvis and Ureter 13 0.072
456
P PTT006 Pituitary Adenoma 57 0.072
457
MRT001 Muir-Torre Syndrome 59 0.072
458
P STR035 Streptococcal Group a Invasive Disease 28 0.072
459
ULC004 Ulcerative Colitis 80 0.072
460
NTM002 Nut Midline Carcinoma 38 0.071
461
AMP003 Ampulla of Vater Neoplasm 39 0.071
462
RTN023 Retinitis 52 0.071
463
ADR009 Adrenal Cortex Disease 40 0.071
464
P CRB059 Cerebellar Degeneration 40 0.071
465
EPD016 Epidermolysis Bullosa 57 0.071
466
c WLM018 Wilms Tumor 5 49 0.071
467
ANX004 Anoxia 49 0.071
468
END016 Endocervicitis 28 0.071
469
MLG076 Malignant Ovarian Surface Epithelial-Stromal Neoplasm 43 0.071
470
MCS004 Mucosal Melanoma 47 0.070
471
NRT004 Neuritis 55 0.070
472
SPL004 Splenic Marginal Zone Lymphoma 52 0.070
473
c MLT156 Multiple Endocrine Neoplasia, Type I 70 0.070
474
P MYP006 Myopia 56 0.070
475
P MLT008 Multinodular Goiter 44 0.069
476
SML036 Small Intestinal Adenocarcinoma 51 0.069
477
CLR014 Clear Cell Adenoma 39 0.069
478
PNM008 Pneumothorax 57 0.069
479
MNT002 Mental Depression 60 0.069
480
P HRD009 Hereditary Wilms' Tumor 46 0.069
481
MCN008 Mucinous Cystadenocarcinoma 41 0.069
482
AML001 Amelanotic Melanoma 42 0.069
483
c VRL010 Viral Hepatitis 59 0.069
484
PRS129 Prostatic Hyperplasia, Benign 47 0.069
485
CTN004 Cutaneous Fibrous Histiocytoma 45 0.069
486
WRN001 Werner Syndrome 70 0.068
487
DDN009 Duodenal Obstruction 34 0.068
488
LYM048 Lymphoma, Large-Cell, Immunoblastic 31 0.068
489
ACN026 Acinar Cell Carcinoma of Pancreas 25 0.068
490
URT001 Urethritis 44 0.068
491
c ADN012 Adenocarcinoma in Situ 45 0.068
492
IMM158 Immune Suppression 57 0.068
493
c MLT151 Multiple Mitochondrial Dysfunctions Syndrome 5 36 0.068
494
PRP019 Peripheral Nervous System Disease 53 0.068
495
PTZ001 Peutz-Jeghers Syndrome 70 0.067
496
P GST044 Gastritis 61 0.067
497
MCR004 Macroglobulinemia 54 0.067
498
AML029 Ameloblastoma 51 0.067
499
LYM067 Lymphoid Leukemia 43 0.067
500
INF058 Inflammatory Myofibroblastic Tumor 49 0.067
501
GRN022 Granulosa Cell Tumor of the Ovary 41 0.067
502
SRT004 Serotonin Syndrome 51 0.067
503
P MYL006 Myeloid Leukemia 69 0.066
504
P XRD010 Xeroderma Pigmentosum, Variant Type 62 0.066
505
TXC002 Toxic Encephalopathy 55 0.066
506
GNG013 Gingivitis 64 0.066
507
P GLM007 Glomerulonephritis 61 0.066
508
APP010 Appendix Cancer 40 0.066
509
RNL018 Renal Pelvis Carcinoma 34 0.066
510
P BLD051 Blood Coagulation Disease 38 0.066
511
ANG046 Angioimmunoblastic T-Cell Lymphoma 46 0.066
512
CHN056 Chondrosarcoma, Extraskeletal Myxoid 44 0.066
513
BRN105 Burn Scar 39 0.065
514
MYP001 Myoepithelioma 42 0.065
515
GBL002 Goblet Cell Carcinoid 37 0.065
516
P PRT096 Peritoneal Mesothelioma 54 0.065
517
FML005 Female Reproductive Endometrioid Cancer 34 0.065
518
PLM019 Pleomorphic Liposarcoma 44 0.065
519
HMT018 Hematopoietic Stem Cell Transplantation 58 0.065
520
P CTN015 Cutaneous T Cell Lymphoma 56 0.065
521
c PRM005 Primary Hyperparathyroidism 59 0.065
522
PLY040 Polymorphous Low-Grade Adenocarcinoma 42 0.065
523
NRF026 Neurofibromatosis, Type Iv, of Riccardi 72 0.065
524
PLM026 Pilomatrixoma 53 0.065
525
P HMR003 Hemorrhagic Disease 61 0.065
526
VSC008 Vascular Hemostatic Disease 36 0.065
527
END007 Endosalpingiosis 32 0.064
528
INF021 Infant Gynecomastia 25 0.064
529
EXT052 Extraskeletal Ewing Sarcoma 37 0.064
530
GRD007 Grade Iii Astrocytoma 56 0.064
531
EMB006 Embryonal Testis Carcinoma 25 0.064
532
P SPR013 Spiradenoma 39 0.064
533
GST028 Gastric Squamous Cell Carcinoma 37 0.064
534
PLM177 Pilomatrix Carcinoma 22 0.064
535
P TCL004 T-Cell Leukemia 50 0.064
536
CLC006 Calcinosis 51 0.064
537
P ALP008 Alopecia 56 0.064
538
DSS009 Disseminated Intravascular Coagulation 56 0.064
539
TNG004 Tongue Disease 37 0.064
540
BLL006 Bullous Pemphigoid 64 0.063
541
FBR019 Fibromatosis 47 0.063
542
P NRV007 Nervous System Disease 75 0.063
543
P PRK001 Porokeratosis 49 0.063
544
OVR054 Ovarian Mucinous Neoplasm 34 0.063
545
PNS010 Penis Squamous Cell Carcinoma 19 0.063
546
TST015 Testicular Disease 43 0.063
547
P UVT001 Uveitis 61 0.063
548
ENP001 Enophthalmos 29 0.063
549
THY106 Thyroglossal Duct Cyst, Familial 25 0.063
550
LYM021 Lymphadenitis 62 0.063
551
P GST047 Gastrointestinal Neuroendocrine Tumor 36 0.063
552
P LNG035 Lung Large Cell Carcinoma 34 0.063
553
P RHB008 Rhabdoid Tumor Predisposition Syndrome 1 44 0.063
554
GNG002 Ganglioneuroma 50 0.062
555
ADN020 Adenosarcoma 43 0.062
556
HDR004 Hidradenoma 41 0.062
557
TBL003 Tubular Adenocarcinoma 43 0.062
558
BRS062 Breast Secretory Carcinoma 35 0.062
559
SCR001 Secretory Meningioma 41 0.062
560
PGT003 Paget Disease, Extramammary 44 0.062
561
PNC019 Pancreatoblastoma 33 0.061
562
OVR060 Ovary Epithelial Cancer 35 0.061
563
MNN006 Meninges Hemangiopericytoma 39 0.061
564
ACT055 Actinomycosis 43 0.061
565
c MLG059 Malignant Struma Ovarii 38 0.061
566
c CNT035 Central Nervous System Disease 65 0.061
567
P GRN010 Granular Cell Tumor 47 0.060
568
P MSN006 Mesenchymoma 37 0.060
569
MSC072 Muscle Cancer 53 0.060
570
PLC003 Placental Site Trophoblastic Tumor 46 0.060
571
PYG006 Pyogenic Granuloma 45 0.060
572
OST003 Osteonecrosis 63 0.060
573
P AMY004 Amyloidosis 69 0.060
574
P MYS005 Myositis 63 0.060
575
SPR008 Supratentorial Primitive Neuroectodermal Tumor 44 0.060
576
UTR011 Uterine Corpus Serous Adenocarcinoma 43 0.060
577
c ADL019 Adult Fibrosarcoma 37 0.059
578
DDF001 Dedifferentiated Liposarcoma 47 0.059
579
PRV003 Perivascular Epithelioid Cell Tumor 42 0.059
580
KPS004 Kaposi Sarcoma 73 0.059
581
PTT037 Pituitary Tumors 49 0.059
582
EPD070 Epidermoid Cysts 46 0.059
583
P PMP001 Pemphigus 55 0.059
584
SPT007 Spitz Nevus 39 0.059
585
ATX038 Ataxia and Polyneuropathy, Adult-Onset 38 0.059
586
c LKM063 Leukemia, Chronic Myeloid 80 0.059
587
P LYD001 Leydig Cell Tumor 47 0.059
588
P HST010 Histiocytosis 60 0.059
589
c SRF005 Surfactant Metabolism Dysfunction, Pulmonary, 3 35 0.059
590
c LKM056 Leukemia, Chronic Lymphocytic 2 35 0.059
591
c SRF008 Surfactant Metabolism Dysfunction, Pulmonary, 4 32 0.059
592
c ACT027 Acute Pancreatitis 61 0.059
593
PRK066 Parkinsonism with Spasticity, X-Linked 31 0.058
594
MXD014 Mixed Ductal-Endocrine Carcinoma 29 0.058
595
LYM051 Lymphomatoid Granulomatosis 51 0.058
596
c TCL001 T-Cell Adult Acute Lymphocytic Leukemia 28 0.058
597
NRM004 Neuroma 51 0.058
598
CRH001 Crohn's Disease 80 0.058
599
P GRF003 Graft-Versus-Host Disease 72 0.058
600
ANS012 Anus Disease 37 0.058
601
c CTR122 Cataract 5, Multiple Types 38 0.058
602
PRN032 Paraneoplastic Cerebellar Degeneration 33 0.058
603
P LFR001 Li-Fraumeni Syndrome 72 0.058
604
DSC009 Discoid Lupus Erythematosus 48 0.058
605
P EXT030 Extraosseous Chondrosarcoma 26 0.058
606
MYX001 Myxopapillary Ependymoma 44 0.058
607
THY009 Thyroid Lymphoma 46 0.057
608
c RCS002 Recessive Dystrophic Epidermolysis Bullosa 55 0.057
609
P CHL066 Cholangitis 52 0.057
610
LYM007 Lymphangioleiomyomatosis 68 0.057
611
P SCL057 Scoliosis, Isolated 1 28 0.057
612
RTN015 Retinal Cancer 53 0.057
613
P HML002 Hemolytic Anemia 62 0.057
614
BRC012 Brucellosis 71 0.057
615
PRP030 Purpura 61 0.057
616
BLD045 Bladder Diverticulum 32 0.057
617
c LKM062 Leukemia, Acute Lymphoblastic 64 0.057
618
SZR001 Sezary's Disease 58 0.057
619
GST052 Gestational Choriocarcinoma 39 0.056
620
P CMR001 Camurati-Engelmann Disease 62 0.056
621
CTN009 Cutaneous Adenocystic Carcinoma 30 0.056
622
c GRV008 Graves Disease 1 52 0.056
623
GNG008 Ganglioneuroblastoma 44 0.056
624
ANP009 Anaplastic Oligodendroglioma 46 0.056
625
GNT002 Giant Cell Glioblastoma 56 0.056
626
PNC056 Pineocytoma 49 0.056
627
PHT003 Phototoxic Dermatitis 39 0.056
628
IMM072 Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome 1 38 0.056
629
BRS042 Breast Scirrhous Carcinoma 32 0.056
630
BZX001 Bazex Syndrome 43 0.055
631
LNG017 Lung Giant Cell Carcinoma 39 0.055
632
OVR017 Ovarian Cystic Teratoma 30 0.055
633
EXT010 Extramedullary Plasmacytoma 52 0.055
634
PNN001 Panniculitis 48 0.055
635
TST043 Testicular Seminoma 36 0.055
636
MYL009 Myelodysplastic Syndrome 75 0.055
637
HSH003 Hashimoto Thyroiditis 67 0.055
638
OVR044 Ovarian Carcinosarcoma 36 0.055
639
PLM032 Pulmonary Blastoma 54 0.055
640
PRS045 Prostatic Hypertrophy 51 0.055
641
c LKM061 Leukemia, Acute Myeloid 81 0.055
642
LNG108 Langerhans Cell Histiocytosis 63 0.055
643
c THR092 Thrombophilia Due to Thrombin Defect 61 0.055
644
c TYP010 Type C Thymoma 34 0.055
645
MTN001 Metanephric Adenoma 31 0.055
646
PRS008 Prostate Small Cell Carcinoma 25 0.055
647
c TBR025 Tuberous Sclerosis 1 63 0.055
648
SBP001 Subependymal Giant Cell Astrocytoma 50 0.055
649
MDL002 Medulloepithelioma 46 0.055
650
BRN015 Bronchiolo-Alveolar Adenocarcinoma 46 0.055
651
LMB002 Lambert-Eaton Myasthenic Syndrome 58 0.055
652
GST023 Gastric Ulcer 57 0.055
653
FSC004 Fasciitis 48 0.055
654
EPT003 Epithelioid Trophoblastic Tumor 33 0.055
655
GSG001 Gas Gangrene 51 0.054
656
P RHM011 Rheumatoid Arthritis 91 0.054
657
P ENC004 Encephalitis 66 0.054
658
SPN035 Spindle Cell Sarcoma 46 0.054
659
CLN044 Colon Adenoma 45 0.054
660
P SRT003 Sertoli-Leydig Cell Tumor 38 0.054
661
EXT001 Extragonadal Seminoma 37 0.054
662
SPN186 Spinal Cord Injury 67 0.054
663
PLY112 Polyarteritis Nodosa, Childhood-Onset 39 0.054
664
GLM008 Glomus Tumor 43 0.054
665
GST016 Gastric Signet Ring Cell Adenocarcinoma 35 0.054
666
P MYL005 Myelofibrosis 75 0.054
667
P ALP009 Alopecia Areata 64 0.054
668
P PSR002 Psoriasis 65 0.053
669
BLT006 Bilateral Breast Cancer 49 0.053
670
ECC008 Eccrine Sweat Gland Neoplasm 26 0.053
671
P LYM025 Lymphedema 63 0.053
672
ANR040 Aneurysm 61 0.053
673
SWL001 Swallowing Disorders 36 0.053
674
c SRF004 Surfactant Metabolism Dysfunction, Pulmonary, 1 33 0.053
675
P ATX030 Ataxia-Telangiectasia 80 0.053
676
PNL013 Penile Disease 37 0.053
677
MXD032 Mixed Germ Cell Tumor 34 0.053
678
CHR076 Choriocarcinoma of the Testis 33 0.053
679
PLY150 Polykaryocytosis Inducer 20 0.053
680
DDN010 Duodenum Cancer 46 0.053
681
P OVR010 Ovarian Brenner Tumor 43 0.053
682
TRT001 Teratocarcinoma 41 0.053
683
NRL005 Neurilemmoma 64 0.053
684
CDQ001 Cauda Equina Syndrome 41 0.053
685
EXT025 Extragonadal Germ Cell Cancer 25 0.053
686
PRP016 Paraplegia 53 0.052
687
HRY003 Hairy Cell Leukemia 60 0.052
688
OST115 Osteonecrosis of the Jaw 41 0.052
689
MCN021 Mucinous Bronchioloalveolar Adenocarcinoma 24 0.052
690
CHL056 Cheilitis 47 0.052
691
LTH001 Lethal Midline Granuloma 40 0.052
692
c PRG018 Paragangliomas 1 57 0.052
693
P NPH012 Nephrotic Syndrome 60 0.052
694
ACR014 Acral Lentiginous Melanoma 49 0.052
695
P DBT009 Diabetes Mellitus 72 0.052
696
LMY014 Leiomyoma, Uterine 61 0.052
697
NDL007 Nodular Goiter 50 0.052
698
ADN075 Adenomyoma 36 0.052
699
NRN006 Neuroendocrine Carcinoma of the Cervix 14 0.052
700
HRP004 Herpes Zoster 61 0.052
701
P EMB005 Embryonal Rhabdomyosarcoma 54 0.051
702
P VGN017 Vaginal Cancer 48 0.051
703
P HRN001 Horner's Syndrome 45 0.051
704
P GRV001 Graves' Disease 62 0.051
705
PRL042 Proliferating Trichilemmal Cyst 38 0.051
706
VLV034 Vulva Squamous Cell Carcinoma 31 0.051
707
KRK001 Krukenberg Carcinoma 30 0.051
708
SMT002 Smooth Muscle Tumor 39 0.051
709
PTT048 Pituitary Adenoma, Prolactin-Secreting 63 0.051
710
INT066 Interstitial Lung Disease 63 0.051
711
OST011 Osteomalacia 52 0.051
712
P PLY018 Polycythemia 60 0.051
713
P END033 Endocarditis 58 0.051
714
BDY004 Body Mass Index Quantitative Trait Locus 11 75 0.050
715
c CNG410 Congenital Heart Defects, Hamartomas of Tongue, and Polysyndactyly 53 0.050
716
c MLG002 Malignant Peritoneal Mesothelioma 51 0.050
717
AMP009 Ampulla of Vater Adenocarcinoma 36 0.050
718
VSC011 Vasculitis 66 0.050
719
HYD005 Hydrocele 51 0.050
720
WLL039 Well-Differentiated Liposarcoma 40 0.050
721
PNL014 Pineal Gland Cancer 36 0.050
722
SBP004 Subependymoma 46 0.050
723
CNT019 Central Neurocytoma 42 0.050
724
JJN007 Jejunal Adenocarcinoma 29 0.050
725
CLC001 Calciphylaxis 53 0.050
726
c ADL023 Adult Medulloblastoma 53 0.050
727
BDY005 Body Mass Index Quantitative Trait Locus 9 49 0.050
728
BDY019 Body Mass Index Quantitative Trait Locus 18 48 0.050
729
BDY017 Body Mass Index Quantitative Trait Locus 14 46 0.050
730
BDY015 Body Mass Index Quantitative Trait Locus 12 46 0.050
731
BDY010 Body Mass Index Quantitative Trait Locus 4 45 0.050
732
BDY011 Body Mass Index Quantitative Trait Locus 10 45 0.050
733
BDY006 Body Mass Index Quantitative Trait Locus 8 42 0.050
734
BDY012 Body Mass Index Quantitative Trait Locus 7 42 0.050
735
CHL010 Childhood Kidney Cell Carcinoma 37 0.049
736
c MLG068 Malignant Glioma 66 0.049
737
BLD032 Bile Duct Adenocarcinoma 39 0.049
738
NDL010 Nodular Hidradenoma 28 0.049
739
OVR011 Ovarian Mucinous Adenocarcinoma 28 0.049
740
P OST002 Osteoporosis 75 0.049
741
P EXT032 Extraosseous Osteosarcoma 38 0.049
742
ECT093 Ectopic Cushing Syndrome 50 0.049
743
P INF038 Influenza 77 0.049
744
TST018 Testicular Yolk Sac Tumor 44 0.049
745
END032 Endometrial Clear Cell Adenocarcinoma 30 0.049
746
P CNJ013 Conjunctivitis 67 0.049
747
c MLT159 Multiple Endocrine Neoplasia, Type Iib 56 0.049
748
P INT070 Intestinal Obstruction 55 0.049
749
SBP002 Subependymal Glioma 41 0.049
750
P BNG013 Benign Breast Phyllodes Tumor 33 0.049
751
CRB024 Cerebral Neuroblastoma 31 0.049
752
PPM002 Ppoma 29 0.049
753
PST011 Pustulosis of Palm and Sole 47 0.049
754
BRR002 Barrett's Adenocarcinoma 43 0.049
755
P BNG032 Benign Mesothelioma 39 0.049
756
XNT002 Xanthogranulomatous Cholecystitis 33 0.049
757
ACR007 Acromegaly 70 0.048
758
PRN014 Paronychia 52 0.048
759
URT010 Ureteral Obstruction 49 0.048
760
PRP021 Peripheral Nervous System Neoplasm 53 0.048
761
c JVN009 Juvenile Pilocytic Astrocytoma 47 0.048
762
P SRT002 Sertoli Cell Tumor 32 0.048
763
P PRP029 Porphyria 62 0.048
764
ACN002 Acanthosis Nigricans 60 0.048
765
P PRT013 Portal Hypertension 59 0.048
766
ESP009 Esophageal Neuroendocrine Tumor 21 0.048
767
ANL016 Anal Margin Carcinoma 20 0.048
768
HMP001 Hemopericardium 34 0.048
769
NRM005 Neuromuscular Disease 60 0.048
770
ADR040 Adrenal Gland Pheochromocytoma 41 0.048
771
P MYX008 Myxoid Chondrosarcoma 31 0.048
772
PRP007 Priapism 49 0.048
773
PPL003 Papillary Cystadenocarcinoma 33 0.048
774
c INF145 Infantile Liver Failure Syndrome 1 33 0.048
775
P CRN035 Cranial Nerve Palsy 42 0.048
776
c PCH010 Pachyonychia Congenita 3 38 0.048
777
P PRC012 Pericardial Effusion 52 0.047
778
OST004 Osteitis Fibrosa 45 0.047
779
HRD029 Hereditary Leiomyomatosis and Renal Cell Cancer 57 0.047
780
GNG004 Ganglioglioma 51 0.047
781
BLD063 Bile Duct Cysts 44 0.047
782
INT071 Intestinal Perforation 44 0.047
783
HPT079 Hepatoid Adenocarcinoma 30 0.047
784
THY096 Thyroid Carcinoma, Hurthle Cell 27 0.047
785
MYL001 Myelitis 52 0.047
786
SML008 Small Intestine Lymphoma 45 0.047
787
P CNT005 Central Nervous System Lymphoma 57 0.047
788
ADR008 Adrenal Adenoma 51 0.047
789
SPN021 Spinal Meningioma 39 0.047
790
PLM018 Pulmonary Sclerosing Hemangioma 37 0.047
791
PNC038 Pancreatic Cystadenocarcinoma 37 0.047
792
RTT004 Rete Testis Adenocarcinoma 25 0.047
793
OVR027 Ovarian Squamous Cell Carcinoma 23 0.047
794
THY092 Thymic Neuroendocrine Carcinoma 13 0.047
795
CRN036 Craniopharyngioma 63 0.046
796
P DBT005 Diabetes Insipidus 54 0.046
797
PLR006 Pleural Cancer 38 0.046
798
MLK001 Milker's Nodule 21 0.046
799
c CHR417 Chronic Graft Versus Host Disease 65 0.046
800
P PNB001 Pineoblastoma 51 0.046
801
P PLY014 Polycystic Kidney Disease 60 0.046
802
GST027 Gastric Lymphoma 53 0.046
803
PPL058 Papilloma of Choroid Plexus 47 0.046
804
PPL035 Papillary Thyroid Microcarcinoma 39 0.046
805
END051 Endolymphatic Sac Tumor 27 0.046
806
P CHR285 Chronic Myelomonocytic Leukemia 63 0.046
807
NRR001 Neuroretinitis 46 0.046
808
CLL003 Cellulitis 53 0.046
809
HML018 Homologous Wasting Disease 18 0.046
810
PLM020 Pleomorphic Xanthoastrocytoma 43 0.046
811
ACT093 Actinic Cheilitis 42 0.046
812
END002 Endometrioid Ovary Carcinoma 34 0.046
813
DSM004 Desmoid Tumor 63 0.046
814
PLM033 Pulmonary Embolism 62 0.046
815
PRN049 Paraneoplastic Pemphigus 45 0.046
816
P PLC011 Pilocytic Astrocytoma 63 0.045
817
BRS004 Breast Angiosarcoma 36 0.045
818
CYS039 Cystic Kidney Disease 49 0.045
819
ATY002 Atypical Choroid Plexus Papilloma 37 0.045
820
P END047 Endophthalmitis 51 0.045
821
ACT118 Acute Non Lymphoblastic Leukemia 32 0.045
822
c LKM060 Leukemia, Acute Lymphoblastic 3 49 0.045
823
c ALZ050 Alzheimer Disease 5 44 0.045
824
P TMP003 Temporal Arteritis 67 0.045
825
DPH001 Diphtheria 63 0.045
826
P OCL002 Oculocutaneous Albinism 57 0.045
827
ALB002 Albinism 45 0.045
828
LNT002 Lentigo Maligna Melanoma 36 0.045
829
LYM014 Lymphangitis 32 0.045
830
CLR018 Clear Cell Meningioma 30 0.045
831
MNP001 Monophasic Synovial Sarcoma 26 0.045
832
P PLY041 Polymyositis 57 0.044
833
LMB024 Limbic Encephalitis 42 0.044
834
TRP003 Triple-Receptor Negative Breast Cancer 38 0.044
835
PRC010 Pericardial Mesothelioma 35 0.044
836
EPT008 Epithelioid Malignant Peripheral Nerve Sheath Tumor 29 0.044
837
SPR024 Supratentorial Cancer 26 0.044
838
MSL001 Measles 64 0.044
839
BCK006 Back Pain 46 0.044
840
PNM010 Pneumothorax, Primary Spontaneous 41 0.044
841
PLX004 Plexopathy 37 0.044
842
c ATS347 Autosomal Dominant Polycystic Kidney Disease 61 0.044
843
P GLM040 Glioma Susceptibility 1 51 0.044
844
NNF001 Non-Functioning Pancreatic Endocrine Tumor 35 0.044
845
MYL002 Myelophthisic Anemia 32 0.044
846
TKN001 Takenouchi-Kosaki Syndrome 30 0.044
847
CLR013 Clear Cell Hidradenoma 25 0.044
848
BDY007 Body Mass Index Quantitative Trait Locus 1 23 0.044
849
P SCL009 Sclerosing Cholangitis 53 0.044
850
STS002 Situs Inversus 48 0.044
851
END035 Endocrine Gland Cancer 48 0.044
852
ANL004 Anal Canal Squamous Cell Carcinoma 40 0.044
853
MLN001 Melanotic Neuroectodermal Tumor 34 0.044
854
SQM018 Squamous Cell Carcinoma of the Oral Tongue 27 0.044
855
SCH010 Schneiderian Carcinoma 26 0.044
856
LCR011 Lacrimal Gland Carcinoma 25 0.044
857
BLL002 Balloon Cell Malignant Melanoma 21 0.044
858
MTT001 Metatypical Basal Cell Carcinoma 19 0.044
859
MCR013 Microphthalmia 61 0.044
860
ACT103 Acute Lymphoblastic Leukemia, Childhood 53 0.044
861
P HRT032 Heart Disease 80 0.043
862
CRD119 Cardiac Arrest 63 0.043
863
SPN369 Spinal Disease 42 0.043
864
P TRN020 Turner Syndrome 69 0.043
865
NTR018 Neutrophilia, Hereditary 46 0.043
866
ADN010 Adenosquamous Cell Lung Carcinoma 45 0.043
867
BLS003 Blastoma 40 0.043
868
ECC005 Eccrine Adenocarcinoma 25 0.043
869
SMN005 Seminal Vesicle Adenocarcinoma 22 0.043
870
AST005 Asthma 83 0.043
871
SVR004 Severe Combined Immunodeficiency 71 0.043
872
HYP020 Hyperprolactinemia 64 0.043
873
GST036 Gastric Leiomyosarcoma 31 0.043
874
HYD058 Hydrops, Lactic Acidosis, and Sideroblastic Anemia 53 0.042
875
c ACT134 Acute Liver Failure 52 0.042
876
TTN003 Tetanus 65 0.042
877
PNC001 Pancytopenia 50 0.042
878
LYM116 Lymph Node Disease 43 0.042
879
RHB001 Rhabdoid Cancer 51 0.042
880
c LFR007 Li-Fraumeni Syndrome 2 46 0.042
881
DYS017 Dysgerminoma of Ovary 36 0.042
882
TRN003 Transverse Colon Cancer 35 0.042
883
MLK004 Malakoplakia 34 0.042
884
BLD028 Bladder Lymphoma 28 0.042
885
PRT034 Peritoneal Serous Adenocarcinoma 25 0.042
886
c MLG022 Malignant Sertoli Cell Tumor 18 0.042
887
GLL015 Gallbladder Squamous Cell Carcinoma 27 0.042
888
RNL019 Renal Pelvis Transitional Cell Carcinoma 18 0.042
889
HMN032 Human Herpesvirus 8 50 0.042
890
BNN003 Bone Inflammation Disease 46 0.042
891
VTL004 Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1 62 0.042
892
END030 End Stage Renal Failure 59 0.042
893
OSS002 Ossifying Fibromyxoid Tumor 29 0.042
894
URT028 Ureter Transitional Cell Carcinoma 15 0.042
895
LRG008 Large Granular Lymphocyte Leukemia 49 0.041
896
PNC016 Pancreatic Cholera 41 0.041
897
P FNC027 Fanconi Anemia, Complementation Group a 78 0.041
898
P CLC063 Celiac Disease 1 65 0.041
899
P SYR003 Syringoma 41 0.041
900
PNC027 Pancreatic Gastrinoma 37 0.041
901
c MLG072 Malignant Leydig Cell Tumor 29 0.041
902
c LYM130 Lymphedema, Hereditary, Ii 55 0.041
903
ERY017 Erythema Elevatum Diutinum 54 0.041
904
PRP036 Peripheral T-Cell Lymphoma 48 0.041
905
PTT004 Pituitary Apoplexy 47 0.041
906
P CNT036 Central Nervous System Germ Cell Tumor 39 0.041
907
c JVN004 Juvenile Myelomonocytic Leukemia 70 0.041
908
OST017 Osteomyelitis 64 0.041
909
P PLY019 Polyneuropathy 58 0.041
910
P CTN003 Cutaneous Lupus Erythematosus 53 0.041
911
ANL022 Anal Fistula 45 0.041
912
ECC001 Eccrine Papillary Adenocarcinoma 23 0.041
913
FTT001 Fatty Liver Disease 62 0.040
914
APP009 Appendix Adenocarcinoma 37 0.040
915
PRC011 Parachordoma 28 0.040
916
DST001 Distal Biliary Tract Carcinoma 14 0.040
917
c LPM012 Lipomatosis, Multiple 64 0.040
918
HYP005 Hypokalemia 53 0.040
919
EXP004 Exophthalmos 50 0.040
920
KLT001 Klatskin's Tumor 47 0.040
921
ONC003 Oncogenic Osteomalacia 45 0.040
922
NDL013 Nodular Regenerative Hyperplasia 53 0.040
923
EMB007 Embryonal Sarcoma 47 0.040
924
GST029 Gastric Cardia Adenocarcinoma 44 0.040
925
P BRN035 Brain Stem Glioma 42 0.040
926
P ASP006 Aspergillosis 65 0.040
927
c ATM011 Autoimmune Hepatitis 63 0.040
928
GLM004 Gliomatosis Cerebri 53 0.040
929
P CYS007 Cystic Nephroma 37 0.040
930
MDS018 Mediastinal Cancer 35 0.040
931
ANL012 Anal Gland Adenocarcinoma 24 0.040
932
TNS013 Tonsil Squamous Cell Carcinoma 22 0.040
933
CHL018 Childhood Medulloblastoma 51 0.040
934
FCL012 Facial Paralysis 50 0.040
935
MYL031 Myeloproliferative Neoplasm 64 0.039
936
P MTR004 Maturity-Onset Diabetes of the Young 62 0.039
937
MYX013 Myxofibrosarcoma 39 0.039
938
WDH001 Wdha Syndrome 31 0.039
939
c PST032 Posterior Urethra Cancer 6 0.039
940
SYS004 Systemic Mastocytosis 65 0.039
941
HYP066 Hyperglycemia 64 0.039
942
CMB081 Combined Immunodeficiency, X-Linked 64 0.039
943
PPL021 Papilledema 50 0.039
944
ANP006 Anaplastic Ependymoma 48 0.039
945
PLS002 Peliosis Hepatis 36 0.039
946
TLS001 Tolosa-Hunt Syndrome 35 0.039
947
RDT014 Radiation Myelitis 17 0.039
948
ALV002 Alveolar Echinococcosis 49 0.039
949
HRT007 Heart Cancer 46 0.039
950
CHN004 Chondroblastoma 40 0.039
951
URC003 Urachal Adenocarcinoma 22 0.039
952
HYP077 Hypertrichosis 49 0.039
953
MYX007 Myxosarcoma 41 0.039
954
ACL001 Acalculous Cholecystitis 39 0.039
955
P THR005 Thrombotic Thrombocytopenic Purpura 63 0.039
956
LYM022 Lymphangioma 53 0.039
957
SLT009 Solitary Bone Cyst 38 0.039
958
ETH009 Ethmoid Sinusitis 34 0.039
959
LKC003 Leukocyte Disease 34 0.039
960
END015 Endometrial Adenosquamous Carcinoma 26 0.039
961
ATM095 Autoimmune Disease 66 0.038
962
ECH003 Echinococcosis 57 0.038
963
END081 Endosteal Hyperostosis, Autosomal Dominant 55 0.038
964
HYD046 Hydatidiform Mole, Recurrent, 1 52 0.038
965
c THR045 Thrombotic Thrombocytopenic Purpura, Congenital 49 0.038
966
ORB006 Orbital Cellulitis 29 0.038
967
DFF031 Diffuse Alveolar Hemorrhage 25 0.038
968
ART016 Aortic Aneurysm 70 0.038
969
BDD001 Budd-Chiari Syndrome 58 0.038
970
P PTY003 Pityriasis Rubra Pilaris 48 0.038
971
P DFF019 Diffuse Gastric Cancer 43 0.038
972
BRS090 Breast Reconstruction 41 0.038
973
OVR050 Ovarian Embryonal Carcinoma 41 0.038
974
AGG003 Aggressive Digital Papillary Adenocarcinoma 33 0.038
975
SCL007 Sclerosing Hepatic Carcinoma 25 0.038
976
P PLY023 Polycystic Liver Disease 53 0.038
977
ACT193 Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22) 53 0.038
978
BNM029 Bone Mineral Density Quantitative Trait Locus 15 39 0.038
979
DLT018 Dilution, Pigmentary 37 0.038
980
MSM014 Mismatch Repair Cancer Syndrome 63 0.038
981
HYP730 Hypogonadotropic Hypogonadism 56 0.038
982
P DDN001 Duodenal Ulcer 53 0.038
983
HMS001 Hemosiderosis 50 0.038
984
FBR002 Fibrosarcoma of Bone 36 0.038
985
BNG041 Benign Metastasizing Leiomyoma 34 0.038
986
PRC002 Paracoccidioidomycosis 59 0.037
987
MYL003 Myeloid Sarcoma 51 0.037
988
PYD002 Pyoderma 51 0.037
989
ERY001 Erysipeloid 32 0.037
990
ATY009 Atypical Polypoid Adenomyoma 31 0.037
991
PNL002 Pineal Parenchymal Tumor of Intermediate Differentiation 29 0.037
992
GST059 Gestational Trophoblastic Tumor 30 0.037
993
EXT053 Extragonadal Nonseminomatous Germ Cell Tumor 27 0.037
994
P ANT014 Anterior Urethra Cancer 6 0.037
995
ING001 Inguinal Hernia 59 0.037
996
HST016 Histiocytic Sarcoma 45 0.037
997
TST025 Testicular Microlithiasis 28 0.037
998
c SBC039 Subacute Cerebellar Degeneration 22 0.037
999
RFR010 Refractory Anemia 48 0.036
1000
TCL002 T-Cell Large Granular Lymphocyte Leukemia 48 0.036
1001
SML014 Small Intestine Leiomyosarcoma 38 0.036
1002
SPN040 Spinal Cancer 37 0.036
1003
PLY001 Polycythemia Vera 75 0.036
1004
APL001 Aplastic Anemia 74 0.036
1005
c ACT073 Acute Leukemia 61 0.036
1006
HDC001 Headache 55 0.036
1007
PGM001 Pigmented Villonodular Synovitis 54 0.036
1008
FBR009 Fibrous Dysplasia 49 0.036
1009
DRF001 Dirofilariasis 40 0.036
1010
PSD084 Pseudo-Meigs Syndrome 22 0.036
1011
URT018 Urethra Transitional Cell Carcinoma 13 0.036
1012
P RSP003 Respiratory Failure 71 0.036
1013
SYN007 Synovitis 61 0.036
1014
BNM005 Bone Marrow Necrosis 26 0.036
1015
URC004 Urachal Cancer 18 0.036
1016
c WLM013 Wilms Tumor 1 69 0.036
1017
P HRD200 Hereditary Breast Ovarian Cancer Syndrome 52 0.036
1018
MCR011 Microinvasive Gastric Cancer 45 0.036
1019
ETH001 Ethmoid Sinus Adenocarcinoma 38 0.036
1020
CHR075 Choriocarcinoma of Ovary 33 0.036
1021
LRY027 Laryngeal Papillomatosis 25 0.036
1022
UND009 Undifferentiated Carcinoma of Stomach 16 0.036
1023
PRT037 Pertussis 70 0.035
1024
P GND004 Gonadal Dysgenesis 50 0.035
1025
P DMY001 Demyelinating Polyneuropathy 46 0.035
1026
FLL013 Follicular Dendritic Cell Sarcoma 43 0.035
1027
KDN015 Kidney Angiomyolipoma 41 0.035
1028
MYB001 Myoblastoma 24 0.035
1029
c CHR089 Chronic Kidney Failure 72 0.035
1030
WLS001 Wilson Disease 72 0.035
1031
c ART138 Aortic Aneurysm, Familial Abdominal, 1 59 0.035
1032
c XRD030 Xeroderma Pigmentosum, Complementation Group C 52 0.035
1033
CHL004 Cholelithiasis 51 0.035
1034
P TYR004 Tyrosinemia 48 0.035
1035
c SBC035 Subacute Cutaneous Lupus Erythematosus 37 0.035
1036
ANL014 Anal Canal Adenocarcinoma 33 0.035
1037
LNR004 Linear Porokeratosis 27 0.035
1038
P ESS003 Essential Thrombocythemia 71 0.035
1039
c PCH015 Pachyonychia Congenita 1 59 0.035
1040
RTN017 Retinal Detachment 59 0.035
1041
MNT310 Mental Retardation, X-Linked, Syndromic, Snyder-Robinson Type 32 0.035
1042
OVR047 Ovarian Cystadenocarcinoma 32 0.035
1043
ALL026 Allergic Hypersensitivity Disease 59 0.034
1044
P HYP083 Hypopituitarism 59 0.034
1045
RSC001 Rosacea 58 0.034
1046
PTT046 Pituitary Hormone Deficiency, Combined, 2 57 0.034
1047
CRY005 Cryptococcosis 54 0.034
1048
PRR002 Pure Red-Cell Aplasia 52 0.034
1049
PLM068 Pulmonary Vein Stenosis 43 0.034
1050
SKN023 Skin Tag 41 0.034
1051
MSN004 Mesenchymal Cell Neoplasm 35 0.034
1052
P EPL003 Epulis 34 0.034
1053
VLV036 Vulvar Disease 33 0.034
1054
BNM022 Bone Mineral Density Quantitative Trait Locus 8 32 0.034
1055
THY042 Thymic Epithelial Tumor 28 0.034
1056
KDN002 Kidney Rhabdoid Cancer 25 0.034
1057
RTR012 Retroperitoneal Liposarcoma 25 0.034
1058
BLD138 Blood Group--Diego System 18 0.034
1059
c SYS001 Systemic Lupus Erythematosus 86 0.034
1060
P PLM034 Pulmonary Emphysema 59 0.034
1061
P BCK002 Beckwith-Wiedemann Syndrome 58 0.034
1062
ATY005 Atypical Teratoid Rhabdoid Tumor 57 0.034
1063
PYD001 Pyoderma Gangrenosum 55 0.034
1064
P OVR046 Ovarian Cyst 52 0.034
1065
P LPM005 Lipomatosis 50 0.034
1066
SLD003 Sialadenitis 49 0.034
1067
MLT016 Multicentric Reticulohistiocytosis 47 0.034
1068
SYN036 Syncope 46 0.034
1069
DND018 Dendritic Cell Tumor 41 0.034
1070
CHP002 Chops Syndrome 40 0.034
1071
OVR013 Ovarian Mucinous Cystadenocarcinoma 32 0.034
1072
ACN010 Acanthoma 32 0.034
1073
SCL056 Sclerosing Cholangitis, Neonatal 32 0.034
1074
OVR062 Ovary Serous Adenocarcinoma 27 0.034
1075
PGT001 Paget's Disease of Bone 60 0.034
1076
SLP005 Sleep Disorder 59 0.034
1077
c CNG029 Congenital Mesoblastic Nephroma 43 0.034
1078
GST010 Gestational Trophoblastic Neoplasm 38 0.034
1079
MXD026 Mixed Glioma 35 0.034
1080
GST087 Gastric Linitis Plastica 15 0.034
1081
SPH001 Sapho Syndrome 54 0.034
1082
c ANT034 Anterior Uveitis 53 0.034
1083
CRN031 Cranial Nerve Disease 45 0.034
1084
PRS063 Paresthesia 36 0.034
1085
INV018 Invasive Mole 24 0.034
1086
GST057 Gastro-Enteropancreatic Neuroendocrine Tumor 15 0.034
1087
PTT009 Pituitary Gland Disease 56 0.033
1088
c PRM226 Primary Central Nervous System Lymphoma 51 0.033
1089
P LCT001 Lactic Acidosis 51 0.033
1090
ACR012 Aicardi Syndrome 49 0.033
1091
VLL003 Villonodular Synovitis 45 0.033
1092
MLG014 Malignant Fibrous Histiocytoma of Bone 43 0.033
1093
EYL005 Eyelid Disease 39 0.033
1094
c NRF024 Neurofibromatosis, Type I 63 0.033
1095
HPT019 Hepatic Encephalopathy 59 0.033
1096
P MMB011 Membranous Nephropathy 55 0.033
1097
ECT026 Ectopic Pregnancy 52 0.033
1098
SPL018 Splenomegaly 45 0.033
1099
CRS001 Crescentic Glomerulonephritis 44 0.033
1100
HPT008 Hepatic Tuberculosis 37 0.033
1101
ASC009 Ascites, Chylous 35 0.033
1102
BRN055 Bronchogenic Cyst 28 0.033
1103
LNT004 Lentigines 52 0.032
1104
P ACT150 Acute Adrenal Insufficiency 51 0.032
1105
MMB001 Membranoproliferative Glomerulonephritis 51 0.032
1106
LYM008 Lymphangiosarcoma 51 0.032
1107
P HMR005 Hemorrhoid 51 0.032
1108
P SCL015 Scleritis 50 0.032
1109
c MLG069 Malignant Hypertension 49 0.032
1110
MYX004 Myxedema 44 0.032
1111
P HYP120 Hypoaldosteronism 40 0.032
1112
ATX031 Ataxia, Combined Cerebellar and Peripheral, with Hearing Loss and Diabetes Mellitus 40 0.032
1113
RHB002 Rhabdoid Meningioma 40 0.032
1114
OVR034 Ovarian Clear Cell Adenocarcinoma 38 0.032
1115
ANG037 Angiomatosis 36 0.032
1116
LTM002 Luteoma 32 0.032
1117
OVR104 Ovarian Melanoma 30 0.032
1118
RCT008 Rectosigmoid Junction Neoplasm 30 0.032
1119
BRN053 Bronchial Adenomas/carcinoids Childhood 22 0.032
1120
BRN021 Brain Sarcoma 22